2[2]Muhlestein JB,Anderson JL, Hmmond EH,et al. Infection with Chlamydia pneumniae accelerates the development of atherosclerosis and treatment with azithromycin prevents it in a rabbit model. Circulation, 1998,97:633-636.
5[5]van der Wal A,Becker A,ven der Loos C, et al. Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology. Circulation, 1994,89:36-44.
6[6]Moreno PR, Falk E,Palacios IF, et al. Macrophage infiltration in acute coronary syndromes:implications for the plaque rupture.Circulation, 1994,90:775-778.
7[7]Shah PK.plaque disruption and thrombosis. Potential role of inflammation and infection. Cardiol Rew,2000,8:31-39.
8[8]Davies MJ,Richardson PD,Woolf N.Risk of thrombosis in human atherosclerotic plaque:role of extracellular lipid,macrophage,and smooth muscle cell content. Br Heart J, 1993,69:377-381.
9[9]Henriques R,ven der Wal AC,ven der Loos CM.Sudden unexpected death in young adults. Eur Heart J, 2002,23:1433-1440.
1[1]Stone G W, Brodie B R, Griffin I J, et al. Clinical and augiographic follow - up after primary stent in acute myocardial infarction. The primary angioplasty in myocardial infarction (PAMI)stent pilot trial[J]. Circulation, 1997, 99:1548 - 1554
2[2]Autman E M, McCabe C H, Gurfinkel E P, et al.Enoxaparin prevents death and cardiac ischemic events in unstable angina/non- Q- wave myocardial, infarction: Results of the Thvobolysis in myocardial infarction(TIMI) Ⅱ B trial[ J ]. Criculation, 1999, 100:1593-1601
4[2]MorgandoA, Sanseverino P, Perotto C, MolinoF, Gai V, Ponzetto A. Helicobacter pylori seropositivity in myocardial infarction. Lancet,1995, 345 ( ): 1 380
5[4]Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s.Nature, 1993, 362:801-809
6[5]Kuller LH, Tracy RP, Shaten J, Meiahn EN. Relation of C-reactive protein and coronary heart disease in the MRFIT neated case-control study-Multiple RisK Factor Intervention Trial. Am J Epidemiol, 1996, 144 (6): 537-547
7[6]Lagrand WK, Niessen HW, Hans WM, Niessen, Wolbink GJ. C-reactive protein colocaliaes with complement in human hearts during acute myocardial infarction. Circulation, 1997, 95 (1): 97-103
8[7]Abdelmouttaleb 1, Danchin N, Ilardo C, Isabelle AG, Angioi M, Lozniewski A,et al. C-Ractive protein and coronary artery disease: Additiond evidence of the implication of an inflammatory process in acute coronay syndromes. Am Heart J,1999, 137:346-351
9[8]Miragliotta G. Helicobacter pylor5 infection and coronary heart disease. Lancet, 1995, 344:751
10[1]Ross R. Atherosclerosis-an inflammatory disease. New Engl J Med, 1999, 340 (2): 115-126
2Braunwald E,Antman EM,Beasley JW,et al.ACC/AHA guideline update for the management of patients with unstable angina and noST segment elevation myocardial infarction[ J ].Circulation,2002,106:1893-1900.
3Anuman EA,Fox KM.Guidelines for the diagnosis and management of unstable angina and No-Q-Myocardial infarction:Proposed Revision[J].Am Heart J,2000,139:461.
